Low expression of METTL14 and ZC3H13 was related to breast cancer progression (increased SBR grade status and NPI classification) and was significantly decreased in ER-, PR- and basal-like, TNBC patients. This evidence concerns the gene ZC3H13 and breast carcinoma.